99 related articles for article (PubMed ID: 33651234)
1. Extracorporeal photopheresis for graft-versus-host disease: the role of patient, transplant, and classification criteria and hematologic values on outcome-results from a large single-center study.
Berger M; Albiani R; Sini B; Fagioli F
Transfusion; 2015 Apr; 55(4):736-47. PubMed ID: 25355659
[TBL] [Abstract][Full Text] [Related]
2. Extracorporeal photopheresis as a promising strategy for the treatment of graft-versus-host disease after CAR T-cell therapy.
Han H; Wang L; Ding Y; Neuber B; Hückelhoven-Krauss A; Lin M; Yao H; Chen Q; Sauer T; Schubert ML; Guo Z; Müller-Tidow C; Schmitt M; Schmitt A
Blood Adv; 2024 Jun; 8(11):2675-2690. PubMed ID: 38359409
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies.
Bruserud Ø; Tvedt TH; Paulsen PQ; Ahmed AB; Gedde-Dahl T; Tjønnfjord GE; Slåstad H; Heldal D; Reikvam H
Cancer Immunol Immunother; 2014 Aug; 63(8):757-77. PubMed ID: 24997173
[TBL] [Abstract][Full Text] [Related]
4. Exosomal-miRNas expression and growth factors released by mononuclear cells of CLAD patients in response to extracorporeal photopheresis.
Bozzini S; Bozza E; Bagnera C; Del Fante C; Barone E; De Vitis S; De Amici M; Testa G; Croce S; Valsecchi C; Avanzini MA; Cacciatore R; Mortellaro C; Viarengo G; Perotti C; Meloni F
J Transl Med; 2024 Mar; 22(1):276. PubMed ID: 38486224
[TBL] [Abstract][Full Text] [Related]
5. Should we use extracorporeal photopheresis more often? Evidence from graft-versus-host disease patients monitored with Treg as a biomarker.
Lopes SM; Roncon S; Pinho AC; Bordalo F; Antunes L; Campilho F; Campos A; Costa-Pereira A
Future Sci OA; 2020 Aug; 6(8):FSO623. PubMed ID: 32983569
[TBL] [Abstract][Full Text] [Related]
6. Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma.
Tsai YC; Schlaepfer T; Ignatova D; Chang YT; Valaperti A; Amarov B; Blanchard G; Pehr K; Vonow-Eisenring M; Urosevic-Maiwald M; Hoetzenecker W; Pascolo S; Iselin C; Fassnacht C; Dimitriou F; Bobrowicz M; Guenova E
Br J Dermatol; 2023 Oct; 189(5):603-611. PubMed ID: 37409661
[TBL] [Abstract][Full Text] [Related]
7. Adverse events in second- and third-line treatments for acute and chronic graft-
Velickovic VM; McIlwaine E; Zhang R; Spelman T
Ther Adv Hematol; 2020; 11():2040620720977039. PubMed ID: 33343855
[TBL] [Abstract][Full Text] [Related]
8. The Role of Extracorporeal Photopheresis in the Management of Graft Versus Host Disease: Narrative Review.
Berhan A; Damtie S; Almaw A; Legesse B; Sharew B; Getie B; Erkihun M; Solomon Y
Immunotargets Ther; 2024; 13():235-246. PubMed ID: 38689598
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain.
Boluda B; Solana-Altabella A; Cano I; Acuña-Cruz E; Rodríguez-Veiga R; Ballesta-López O; Megías-Vericat JE; Martínez-Cuadrón D; Gómez I; Solves P; Lorenzo I; Piñana JL; Sanz J; Guerreiro M; Montoro Gómez J; Díaz-González A; Marco J; Blanco A; Sanz MÁ; Montesinos P
J Clin Apher; 2021 Aug; 36(4):612-620. PubMed ID: 33964038
[TBL] [Abstract][Full Text] [Related]
10. Effects of Ramadan Fasting on Extracorporeal Photopheresis Outcomes.
Castillo-Aleman YM; Martinez MA; Ventura-Carmenate Y; Villegas-Valverde CA; Bencomo-Hernandez AA; Rivero Jimenez RA; Al-Kaabi FM
Cureus; 2023 Oct; 15(10):e47612. PubMed ID: 37886650
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in graft-versus-host disease.
Flinn AM; Gennery AR
Fac Rev; 2023; 12():4. PubMed ID: 36923700
[TBL] [Abstract][Full Text] [Related]
12. Extracorporeal photopheresis as an immunomodulatory treatment modality for chronic GvHD and the importance of emerging biomarkers.
Bojanic I; Worel N; Pacini CP; Stary G; Piekarska A; Flinn AM; Schell KJ; Gennery AR; Knobler R; Lacerda JF; Greinix HT; Pulanic D; Crossland RE
Front Immunol; 2023; 14():1086006. PubMed ID: 36875063
[TBL] [Abstract][Full Text] [Related]
13. Current Prophylaxis and Treatment Approaches for Acute Graft-Versus-Host Disease in Haematopoietic Stem Cell Transplantation for Children With Acute Lymphoblastic Leukaemia.
Wölfl M; Qayed M; Benitez Carabante MI; Sykora T; Bonig H; Lawitschka A; Diaz-de-Heredia C
Front Pediatr; 2021; 9():784377. PubMed ID: 35071133
[TBL] [Abstract][Full Text] [Related]
14. Thymopoiesis, Alterations in Dendritic Cells and Tregs, and Reduced T Cell Activation in Successful Extracorporeal Photopheresis Treatment of GVHD.
Flinn AM; Ehrlich A; Roberts C; Wang XN; Chou J; Gennery AR
J Clin Immunol; 2021 Jul; 41(5):1016-1030. PubMed ID: 33651234
[TBL] [Abstract][Full Text] [Related]
15. Thymopoiesis following HSCT; a retrospective review comparing interventions for aGVHD in a pediatric cohort.
Flinn AM; Roberts CF; Slatter MA; Skinner R; Robson H; Lawrence J; Guest J; Gennery AR
Clin Immunol; 2018 Aug; 193():33-37. PubMed ID: 29395846
[TBL] [Abstract][Full Text] [Related]
16. Modulation of B Cells and Homing Marker on NK Cells Through Extracorporeal Photopheresis in Patients With Steroid-Refractory/Resistant Graft-Vs.-Host Disease Without Hampering Anti-viral/Anti-leukemic Effects.
Wang L; Ni M; Hückelhoven-Krauss A; Sellner L; Hoffmann JM; Neuber B; Luft T; Hegenbart U; Schönland S; Kleist C; Sill M; Chen BA; Wuchter P; Eckstein V; Krüger W; Hilgendorf I; Yerushalmi R; Nagler A; Müller-Tidow C; Ho AD; Dreger P; Schmitt M; Schmitt A
Front Immunol; 2018; 9():2207. PubMed ID: 30349527
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience.
Calore E; Marson P; Pillon M; Tumino M; Tison T; Mainardi C; De Silvestro G; Rossin S; Franceschetto G; Carraro E; Pescarin M; Varotto S; Destro R; Gazzola MV; Basso G; Messina C
Biol Blood Marrow Transplant; 2015 Nov; 21(11):1963-72. PubMed ID: 26183078
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Bassler D
Cochrane Database Syst Rev; 2014 Feb; (2):CD009759. PubMed ID: 24569960
[TBL] [Abstract][Full Text] [Related]
19. Extracorporeal photopheresis versus standard treatment for acute graft-versus-host disease after haematopoietic stem cell transplantation in paediatric patients.
Weitz M; Strahm B; Meerpohl JJ; Schmidt M; Bassler D
Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD009759. PubMed ID: 26666580
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
